Prevalence of Hepatitis B Virus among Women of Child-Bearing Age in Port Harcourt, Nigeria

Main Article Content

Iheanyi O. Okonko
Onyekachi L. Udo
Tochi I. Cookey
Chisom C. Adim

Abstract

Aim: Hepatitis B virus among women of child bearing age is a major determinant of perinatal hepatitis B transmission. The risk of developing liver-related complications, such as cirrhosis and hepatocellular carcinomas increases as patient progresses from acute to chronic stage of the infection. The aim of this study was to determine the prevalence of HBV among women of child bearing age in Port Harcourt, Nigeria.

Study Design:  Cross-sectional study.

Place and Duration of Study: University of Port Harcourt, Nigeria, between June 2012 and July 2015.

Methods: A total of 89 women of child bearing age in Port Harcourt, Nigeria (ages 15-45 years) were screened for the presence of HBsAg. The presence of HBV was determined using third-generation enzyme linked immunosorbent assay (ELISA) (Bio-Rad, France).

Results: The results showed an overall HBsAg prevalence of 12.4%. Married women (14.3%) were found to be more infected with the highest prevalence rate recorded among the non-students (14.6%) and those within the 25-45 years age group (14%).

Conclusion: This study has shown that the prevalence of HBV among women of child-bearing age is high. Health education on the possible mode of transmission and the introduction of routine screening of women in health facilities will grossly help in reducing the rate of infection.

Keywords:
HBV, women, prevalence, Nigeria

Article Details

How to Cite
Okonko, I. O., Udo, O. L., Cookey, T. I., & Adim, C. C. (2020). Prevalence of Hepatitis B Virus among Women of Child-Bearing Age in Port Harcourt, Nigeria. Asian Journal of Immunology, 4(4), 1-7. Retrieved from https://journalaji.com/index.php/AJI/article/view/30140
Section
Original Research Article

References

Leung N. Chronic hepatitis B in Asian women of childbearing age. Hepatology International. 2009;3 Suppl 1(Suppl 1):24–31.

WHO. Global hepatitis report; 2008. Available:http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. Accessed 18 Feb 2018.

WHO. Hepatitis B. Fact Sheet No. 204. Geneva, Switzerland: World Health Organization; 2011.

WHO. Hepatitis B. Fact Sheet No. 204. Geneva, Switzerland: World Health Organization; 2011.

Teo E-K, Lok ASF. Epidemiology, transmission, and prevention of hepatitis B virus infection in Up-To-Date. Edited by Basow DS. Waltham, MA; 2009.

CDC. Viral Hepatitis-Hepatitis B; 2020. Available:https://www.cdc.gov/hepatitis/hbv/index.htm. Accessed August 6, 2020.

Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS. Clinical characteristics of fulminant hepatitis in pregnancy. World Journal of Gastroenterology. 2005;11(29):4600–4603.

Hannes H, Jonas H, Hanns‐Ulrich M, Catherine W, Michael AH, Rachel HW, Jonas FL, Olof S. Outcomes of pregnancy in mothers with cirrhosis: a national population‐based cohort study of 1.3 million pregnancies- hepatology communications. American Association for the Study of Liver Diseases. 2018;2(11).

Jatau ED, Yabaya A. Seroprevalence of hepatitis B virus in pregnant women attending a clinic in Zaria, Nigeria. Science World Journal. 2009;4:7-9.

Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. Journal of Viral Hepatitis. 1999;6:135-9.

Adabara NU, Ajal OO, Momohjimoh A, Hashimu Z, Agabi AYV. Prevalence of hepatitis B Virus among women attending antenatal clinic in the general hospital, Minna, Niger State. Shiraz E-Medical Journal. 2012;13(1):28-32.

Eustace BB, Alawode RA, Mohammed AB, Babalola BS. Prevalence of Hepatitis B virus in Nigeria: Review Update. Annal of Public Health & Epidemiology. 2019;1(1). APHE.MS.ID.000501.

Adegbesan-Omilabu M, Okunade K, Gbadegesin A, Olowoselu O, Oluwole A, Omilabu S. Seroprevalence of hepatitis B virus infection among pregnant women at the antenatal booking clinic of a Tertiary Hospital in Lagos Nigeria. The Nigerian Journal of Clinical Practice. 2015;18:819-23

Anaedobe CG, Fowotade A, Omoruyi CE, Bakare RA. Prevalence, sociodemographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria. The Pan African Medical Journal. 20:406.

Akani CI, Ojule AC, Opurum HC, Ejilemele AA. Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Nigerian Postgraduate Medical Journal. 2005;12(4):266-270.

Harry TO, Bajani MD, Moses AE. Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East African Medical Journal. 1994;71(9):596-597.

Nwokedi EE, Emokpae MA, Taura AA, Dutse AI. The trends of hepatitis B surface antigenemia among teaching hospital patients in Kano. African Journal of Clinical Experimental Microbiology. 2006;7:143-147.

Tanga AT, Teshome MA, Hiko D. Sero-prevalence of hepatitis B virus and associated factors among pregnant women in Gambella hospital, South Western Ethiopia: facility based cross-sectional study. BMC Infect Dis. 2009;19:602. Available:https://doi.org/10.1186/s12879-019-4220-z

Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. New England Journal of Medicine. 1975;292:771–774.

Macfarlane SB. Conducting a descriptive survey: 2. choosing a sampling strategy. Tropical Doctors. 1997;27(1):14-21.

Nongo BH, Agida TE, Oghenebuk U, Yunusa T. Seroprevalence of hepatitis B virus among antenatal attendees at the University of Abuja Teaching Hospital, Nigeria. Ann Nigerian Med. 2016;10:58-62.

Obi RK, Umeh S, Okurede OH, Iroagba LL. Prevalence of hepatitis B virus infection among pregnant women in antenatal clinic in Port Harcourt, Nigeria. Clin Exp Microbiol. 2006;7:78-82.

Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol Rev. 2006;28:112-25.

Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. 1996;38(2):S5-S12.

Clegg T. Hepatitis B surface and e antigen seropositivity in mothers and cord blood at Port Moresby General Hospital: implication for a control program. Papua New Guinea Medical Journal. 1991;34:234- 237.

Collenberg E, Ouedraogo T, Ganamé J et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysis. J. Med. Virol. 2006;78(5):683–692.

Kong Kl, Cho Y, lee SS. The declining HBsAg carriage rate in pregnant women in Hong Kong. Epidemiology and Infections. 1997;199:281-283.

Okonko IO, Udeze AO. Detection of hepatitis B surface antigen (HbsAg) among pregnant women attending Antenatal clinic at O.L.A. Catholic Hospital, Oluyoro, Ibadan, Oyo State, South-Western Nigeria. 2011;9:54-60.

Agarry OO, Lekwot GZ. Prevalence of hepatitis B virus and hepatitis C virus in ante-natal patients in Gwagwalada- Abuja, Nigeria. Report and Opinion. 2010;2(7):48-50.

Adeyemi AB, Enabor OO, Ugwu IA, Abraham OA, Bello FA, Olayemi O. Prevalence of antenatal hepatitis B infection in tertiary and non-tertiary health facilities in Ibadan, Nigeria. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria. 2014;23(3):248-53.

Awole, M., Gebre-Selassie, S. (2005). Seroprevalence of hepatitis B surface antigen and its risks factors among pregnant women in Jimma, South Ethiopia. Ethiopian J of Health and Develop. 2015;19(1):45-50.

Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM, Ojo TO. Risk factors for hepatitis B virus infection among, pregnant women in lagos, Nigeria. Acta Obstetricia et Gynecologica. 2010;89:1024–1028.

Onakewhor JUE, Offor E, Okonnofua FE. Maternal neonatal sero-Prevalence of Hepatitis B surface antigen (HBsAg) in Benin City. J of Gynecol. 2001;21(6):583-586.

Agbede OO, Iseniyi JO, Kolawole MO, Ojuowa A. Risk factors and sero-Prevalence of Hepatitis B surface antigenemia in mothers and their preschool age children in Ilorin, Nigeria. Therapy. 2007;4(1):67-72.

Ndams IS, Joshua IA, Luka SA, Sadiq HO. Epidemiology of Hepatitis B infection among pregnant women in Minna, Nigeria. Science World Journal. 2008;3(3):5-8.

Ojo OO, Anibijuwon II. Determination of antibodies to Hepatitis B Virus in pregnant women in Akure, Ondo State, Nigeria. Continental Journal of Microbiology. 2009;3:6-10.

Mehment D, Meliksah E, Serif Y, Gunay S, Tunneer O, Zeynep S. Prevalence of hepatitis B infection in the southern region of Turkey: Comparison of risk factors for HBV infection in rural and urban areas. Japan Journal of infectious Diseases. 2005;58:15-19.

Motta-Castro ARC, Yoshida CFT, Lemons ERS, Olivetra JM, Cunha RV. Seroprevalence of hepatitis B Virus infection among Afro-descent community in Brasil. Memorias do insitu oswal cruz Rio de Jane. 2003;98(1):13-17.

Yakasai IA, Rabi'u A, Idris SA, Saidu AI. Sero-prevalence of Hepatitis B Virus Infection and its Risk factors among Pregnant Women Attending Antenatal Clinic at Aminu Kano Teaching Hospital, Kano, Nigeria. Journal of Basic and Clinical Reproduction Sciences. 2017;1:49-55.

Siirsena ND, Njoku MO, Isamade E, Barau C, Jelpe D. Carriage rate of HBsAg in Urban community in Jos. Niger postgrad Med J. 2002;9(1):7-10.

Ezegbudo CN, Agbonlahor DE, Nwobu GO, Igwe CU, Agba MI, Okpaba HO and Ikaraoha CI. The seroprevalence of hepatitis B surface antigen and human immunodeficiency virus among pregnant women in Anambra State, Nigeria. Shiraz E-Medical Journal. 2004;5(2):1–8.

Uneke CJ, Ogbu PUI, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis B surface antigen among blood donors in Jos. Memorias do Isitu Oswal Cruz Rio de Jane. 2005;98(1):13-17.